Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia
AssigneeH. Lundbeck A/S
InventorsRené Holm, Lone Bruun
Life of this patent
Estimating the term…
Abstract
The present invention relates to 4-((1R,3S)-6-chloro-3-phenyl-indan-1yl)-1,2,2-trimethyl-piperazine and the salts thereof with activity at dopamine D1 and D2 receptors as well as the serotonin 5HT2 receptor for the treatment of diseases in the central nervous system in a once weekly dosing regime.
Claims13
1-5. (canceled)
The method of claim 9, wherein the psychosis is schizophrenia Schizophreniform Disorder, Schizoaffective Disorder, Delusional Disorder, Brief Psychotic Disorder, Shared Psychotic Disorder or bipolar disorder.
7-8. (canceled)
A method of treating a patient suffering from a psychosis, comprising Compound (I) semiweekly, weekly or biweekly in a dose corresponding to between 20 mg/week and 50 mg/week calculated as the free base of Compound (I).
10-11. (canceled)
Dependencies are inferred from the claim text.